It’s often under-diagnosed because of atypical presentation and, in the past, reluctance to perform duodenal biopsy, long the gold standard for diagnosis. But newer, non-invasive blood tests have greatly simplified screening and diagnosis. The tissue transglutaminase antibody test, which has a sensitivity of 95% and specificity approaching 100%, is now commonly used to screen and diagnose patients.
Dissimilar to with numerous different growths, your specialist might be really sure around an analysis of kidney cancer without a biopsy. Here and there, a biopsy will be done to affirm the analysis.we encourage our patients’ participation in their own treatment which helps them to make informed decisions